PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell linesMD Coltrera and AM Gown Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle 98195. Monoclonal antibodies (MAb) to a 36 KD protein, proliferating cell nuclear antigen (PCNA/cyclin), have been previously shown to be capable of identifying proliferating cells in vitro as well as in alcohol- fixed, paraffin-embedded tissue specimens. The routine use of these anti-PCNA/cyclin MAb in investigative studies and in diagnostic pathology requires a clearer understanding of the distribution of PCNA/cyclin in the different cell populations found in tissue specimens. We therefore compared the ability of MAb to three nucleus- associated proliferation markers (MAb 19A2 to PCNA/cyclin; Ki-67 to an undefined proliferation-related marker; BU-1 to 5'-bromodeoxyuridine (BrdU) incorporated into DNA) to identify the proliferating cell fraction of various cells in vitro. The cell lines were chosen to represent a spectrum of proliferation rates (high to low) and cell lineage (mesenchymal vs epithelial, non-transformed vs malignant): (a) HeLa and A-431 (two malignant carcinoma cell lines with high proliferation rates); (b) SK-5 (a non-transformed fibroblast cell line with a low proliferation rate); (c) HUVE (a non-transformed human umbilical vein endothelial cell line with a low proliferation rate). Single and double labeling immunofluorescence studies were performed after uniform 1-hr incubations with BrdU. Comparison of the overlapping distributions of detectable PCNA/cyclin expression and BrdU incorporation demonstrated substantial qualitative and quantitative differences between the different cell lines. In two of the four cell lines (HeLa, A-431) the BrdU staining distributions formed inclusive subsets of the PCNA-positive cell populations. In the HUVE cell line the two populations overlapped incompletely. In one cell line, SK-5, the two populations were mutually exclusive. MAb Ki-67 demonstrated a pattern in the SK-5 cell line that was strongly predictive of PCNA positivity, while showing no associated patterns in the other three cell lines. We conclude that PCNA/cyclin expression detected by MAb may define different cell subpopulations in different cell types relative to those incorporating BrdU or expressing the target antigen for Ki-67. This has implications for the clinical study of mixed cell populations using these antibodies.
Volume 39,
Issue 1,
pp. 23-30,
01/01/1991
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
L. Muskhelishvili, S. K. Wingard, and J. R. Latendresse Proliferating Cell Nuclear Antigen--A Marker for Ovarian Follicle Counts Toxicol Pathol, April 1, 2005; 33(3): 365 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Muskhelishvili, J. R. Latendresse, R. L. Kodell, and E. B. Henderson Evaluation of Cell Proliferation in Rat Tissues with BrdU, PCNA, Ki-67(MIB-5) Immunohistochemistry and In Situ Hybridization for Histone mRNA J. Histochem. Cytochem., December 1, 2003; 51(12): 1681 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Peng, O. A. Carretero, L. Raij, F. Yang, A. Kapke, and N.-E. Rhaleb Antifibrotic Effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on the Heart and Kidney in Aldosterone-Salt Hypertensive Rats Hypertension, February 1, 2001; 37(2): 794 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. McKeever Insights About Brain Tumors Gained Through Immunohistochemistry and in Situ Hybridization of Nuclear and Phenotypic Markers J. Histochem. Cytochem., May 1, 1998; 46(5): 585 - 594. [Abstract] [Full Text] |
||||
![]() |
A. Chaux, X. M. Ruan, M. C. Fishbein, M. Sandhu, and J. M. Matloff INFLUENCE OF VEIN VALVES IN THE DEVELOPMENT OF ARTERIOSCLEROSIS IN VENOARTERIAL GRAFTS IN THE RABBIT J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1381 - 1390. [Abstract] [Full Text] |
||||
![]() |
J. Davis, J. Oberholtzer, F. Burns, and M. Greene Molecular cloning and characterization of an inner ear-specific structural protein Science, February 17, 1995; 267(5200): 1031 - 1034. [Abstract] [PDF] |
||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |